Your browser doesn't support javascript.
loading
Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation.
Sandoval, Yader; Lewis, Bradley R; Mehta, Ramila A; Ola, Olatunde; Knott, Jonathan D; De Michieli, Laura; Akula, Ashok; Lobo, Ronstan; Yang, Eric H; Gharacholou, S Michael; Dworak, Marshall; Crockford, Erika; Rastas, Nicholas; Grube, Eric; Karturi, Swetha; Wohlrab, Scott; Hodge, David O; Tak, Tahir; Cagin, Charles; Gulati, Rajiv; Jaffe, Allan S.
Affiliation
  • Sandoval Y; Department of Cardiovascular Diseases (Y.L., L.D.M., R.L., R.G., A.S.J.), Mayo Clinic, Rochester, MN.
  • Lewis BR; Division of Biomedical Statistics and Informatics (B.R.L.), Mayo Clinic, Rochester, MN.
  • Mehta RA; Department of Health Sciences Research (R.A.M.), Mayo College of Medicine, Rochester, MN.
  • Ola O; Division of Hospital Internal Medicine (O.O., A.A., S.K..), Mayo Clinic Health System, La Crosse, WI.
  • Knott JD; Center for Clinical and Translational Science, Mayo Clinic Graduate School of Biomedical Sciences, Rochester MN (O.O., A.A.).
  • De Michieli L; Department of Internal Medicine (J.D.K.), Mayo Clinic, Rochester, MN.
  • Akula A; Department of Cardiovascular Diseases (Y.L., L.D.M., R.L., R.G., A.S.J.), Mayo Clinic, Rochester, MN.
  • Lobo R; Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Italy (L.D.M.).
  • Yang EH; Division of Hospital Internal Medicine (O.O., A.A., S.K..), Mayo Clinic Health System, La Crosse, WI.
  • Gharacholou SM; Center for Clinical and Translational Science, Mayo Clinic Graduate School of Biomedical Sciences, Rochester MN (O.O., A.A.).
  • Dworak M; Department of Cardiovascular Diseases (Y.L., L.D.M., R.L., R.G., A.S.J.), Mayo Clinic, Rochester, MN.
  • Crockford E; Department of Cardiovascular Diseases, Mayo Clinic, Phoenix, AZ (E.H.Y.).
  • Rastas N; Department of Cardiovascular Diseases, Mayo Clinic, Jacksonville, FL (S.M.G.).
  • Grube E; Department of Cardiovascular Diseases (M.D., N.R., T.T., C.C.), Mayo Clinic Health System, La Crosse, WI.
  • Karturi S; Department of Family Medicine (E.C.), Mayo Clinic Health System, La Crosse, WI.
  • Wohlrab S; Department of Cardiovascular Diseases (M.D., N.R., T.T., C.C.), Mayo Clinic Health System, La Crosse, WI.
  • Hodge DO; Department of Emergency Medicine (E.G.), Mayo Clinic Health System, La Crosse, WI.
  • Tak T; Division of Hospital Internal Medicine (O.O., A.A., S.K..), Mayo Clinic Health System, La Crosse, WI.
  • Cagin C; Department of Laboratory Medicine and Pathology (S.W.), Mayo Clinic Health System, La Crosse, WI.
  • Gulati R; Department of Health Sciences Research, Mayo College of Medicine, Jacksonville, FL (D.O.H.).
  • Jaffe AS; Department of Cardiovascular Diseases (M.D., N.R., T.T., C.C.), Mayo Clinic Health System, La Crosse, WI.
Circulation ; 145(23): 1708-1719, 2022 06 07.
Article in En | MEDLINE | ID: mdl-35535607
ABSTRACT

BACKGROUND:

There are good data to support using a single high-sensitivity cardiac troponin T (hs-cTnT) below the limit of detection of 5 ng/L to exclude acute myocardial infarction. Per the US Food and Drug Administration, hs-cTnT can only report to the limit of quantitation of 6 ng/L, a threshold for which there are limited data. Our goal was to determine whether a single hs-cTnT below the limit of quantitation of 6 ng/L is a safe strategy to identify patients at low risk for acute myocardial injury and infarction.

METHODS:

The efficacy (proportion identified as low risk based on baseline hs-cTnT<6 ng/L) of identifying low-risk patients was examined in a multicenter (n=22 sites) US cohort study of emergency department patients undergoing at least 1 hs-cTnT (CV Data Mart Biomarker cohort). We then determined the performance of a single hs-cTnT<6 ng/L (biomarker alone) to exclude acute myocardial injury (subsequent hs-cTnT >99th percentile in those with an initial hs-cTnT<6 ng/L). The clinically intended rule-out strategy combining a nonischemic ECG with a baseline hs-cTnT<6 ng/L was subsequently tested in an adjudicated cohort in which the diagnostic performance for ruling out acute myocardial infarction and safety (myocardial infarction or death at 30 days) were evaluated.

RESULTS:

A total of 85 610 patients were evaluated in the CV Data Mart Biomarker cohort, among which 24 646 (29%) had a baseline hs-cTnT<6 ng/L. Women were more likely than men to have hs-cTnT<6 ng/L (38% versus 20%, P<0.0001). Among 11 962 patients with baseline hs-cTnT<6 ng/L and serial measurements, only 1.2% developed acute myocardial injury, resulting in a negative predictive value of 98.8% (95% CI, 98.6-99.0) and sensitivity of 99.6% (95% CI, 99.5-99.6). In the adjudicated cohort, a nonischemic ECG with hs-cTnT<6 ng/L identified 33% of patients (610/1849) as low risk and resulted in a negative predictive value and sensitivity of 100% and a 30-day rate of 0.2% for myocardial infarction or death.

CONCLUSIONS:

A single hs-cTnT below the limit of quantitation of 6 ng/L is a safe and rapid method to identify a substantial number of patients at very low risk for acute myocardial injury and infarction.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Injuries / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Circulation Year: 2022 Type: Article Affiliation country: Mongolia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Injuries / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Circulation Year: 2022 Type: Article Affiliation country: Mongolia